Zobrazeno 1 - 10
of 401
pro vyhledávání: '"MJ Martinez"'
Publikováno v:
BMC Musculoskeletal Disorders, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background We assessed quality of life (QoL) of patients undergoing surgery for proximal femur fracture and performed a cost-effectiveness analysis of haemostatic drugs for reducing postoperative bleeding. Methods We analysed data from an op
Externí odkaz:
https://doaj.org/article/6cd6ca64fa16402aa7744c1a5a6d3816
Autor:
MJ Martinez Membrive, F Rueda Sobella, C Garcia Garcia, C Labata Salvador, T Oliveras Vila, S Montero Aradas, M Ferrer Massot, N El Ouaddi, J Serra Flores, J Lupon Roses, A Bayes Genis
Publikováno v:
European Heart Journal. Acute Cardiovascular Care. 11
Funding Acknowledgements Type of funding sources: Public hospital(s). Main funding source(s): Hospital Germans Trias i Pujol Background Cardiogenic shock (CS) is a severe complication of myocardial infarction (MI) and carries a high mortality. Clinic
Autor:
A Ganfornina Andrades, C Rodriguez Moreta, M Corrales Paz, MJ Martinez Bautista, MV Manzano Martin
Publikováno v:
Section 5: Patient safety and quality assurance.
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Palbociclib and ribociclib are oral inhibitors of cyclin dependent kinases for firstline and secondline treatment of hormone receptor (HR) positive, HER2 negative locally advanced or metastatic breast cancer (BC). The most c
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Nivolumab and pembrolizumab are highly selective blockers of anti-programmed death-1 (PD-1). Nivolumab was authorised to be administered in weight based dosing (WBD) schedules at 3 mg/kg every 2 weeks (w) for all indications
Autor:
C Santos Rodriguez, I Moyano Prieto, G Blanco Sánchez, MJ Huertas Fernandez, MJ Martinez Bautista, M Domínguez López, A Salguero Olid, ME Rodriguez Mateos, F García Martín, MV Manzano Martin
Publikováno v:
Clinical pharmacy.
Background Until the arrival of new oral drugs to our hospital (dimethyl fumarate and teriflunomide), the drugs prescribed for the treatment of mild forms of relapsing remitting multiple sclerosis (RRMS) were for parenteral administration. Nowadays,
Autor:
P. Ramirez Daffos, MJ Martinez Bautista, A Salguero Olid, M.J. Gómez Reina, M Domínguez López, A. Quilez Cutillas, I. Iglesias Lozano, G Blanco Sánchez
Publikováno v:
European Journal of Cancer. 72:S48-S49
Publikováno v:
Annals of Oncology. 28:x37
Publikováno v:
Value in Health. 20:A507